<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02694419</url>
  </required_header>
  <id_info>
    <org_study_id>PCOS</org_study_id>
    <nct_id>NCT02694419</nct_id>
  </id_info>
  <brief_title>The Effect of Obesity on Endometrium in PCOS</brief_title>
  <acronym>OB-PCO</acronym>
  <official_title>Effect of Body Weight on Endometrial Ultrasonographic Characteristics in Polycystic Ovary Syndrome Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assiut University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assiut University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The effect of Polycystic Ovary Syndrome (PCOS) with or without obesity has received a few
      attentions. There is a lack of evidence to whether the BMI affects the endometrial blood
      flow, which is necessary for implantation.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">February 2016</start_date>
  <completion_date type="Actual">April 2017</completion_date>
  <primary_completion_date type="Actual">December 2016</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>the mean difference in Doppler indices (VI-FI-VFI)</measure>
    <time_frame>24 hours</time_frame>
  </primary_outcome>
  <number_of_groups>4</number_of_groups>
  <enrollment type="Actual">100</enrollment>
  <condition>Body Weight</condition>
  <condition>Polycystic Ovary Syndrome</condition>
  <arm_group>
    <arm_group_label>obese/PCO</arm_group_label>
    <description>Women with PCOS who are overweight\obese with BMI ≥ 25 kg/m2.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>normal weight/PCO</arm_group_label>
    <description>Women with PCOS who are normal weight with BMI &lt; 25 kg/m2.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Obese/fertile</arm_group_label>
    <description>Fertile regularly menstruating women with at least one previous spontaneous pregnancy who are overweight\obese with BMI ≥ 25 kg/m2.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>normal weight/fertile</arm_group_label>
    <description>Fertile regularly menstruating women with at least one previous spontaneous pregnancy who are normal weight with BMI &lt; 25 kg/m2.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Doppler evaluation</intervention_name>
    <description>Endometrial volume, endometrial and subendometrial vascularity indices are measured by 3D power Doppler</description>
    <arm_group_label>obese/PCO</arm_group_label>
    <arm_group_label>normal weight/PCO</arm_group_label>
    <arm_group_label>Obese/fertile</arm_group_label>
    <arm_group_label>normal weight/fertile</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        100 women were recruited from gynecology clinic of Women Health Hospital
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Women with PCOS are diagnosed according to Rotterdam criteria, (Rotterdam and
             ASRM-Sponsored, 2004)by the presence of two out of the following three: oligomenorrhea
             (absence of menses for 35-182 days) or amenorrhea (absence of menses for &gt;182 days),
             signs or symptoms of hyperandrogenism (acne, hirsutism), US showing polycystic
             ovaries.

          -  Fertile women had regular menstruation, with at least one previous spontaneous
             pregnancy.

        Exclusion Criteria:

          -  Women known to have hepatic or renal dysfunction, Diabetes mellitus, hypertension, or
             cardiovascular disease.

          -  If they have used induction of ovulation drugs for the last three months.

          -  If they have used hormonal contraception in the last three months.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Ahmed Abbas</name>
      <address>
        <city>Assiut</city>
        <state>Cairo</state>
        <zip>002</zip>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>August 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 24, 2016</study_first_submitted>
  <study_first_submitted_qc>February 26, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 29, 2016</study_first_posted>
  <last_update_submitted>August 10, 2017</last_update_submitted>
  <last_update_submitted_qc>August 10, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">August 11, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Assiut University</investigator_affiliation>
    <investigator_full_name>Ahmed Mohamed Abbas</investigator_full_name>
    <investigator_title>Dr</investigator_title>
  </responsible_party>
  <keyword>endometrium</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Syndrome</mesh_term>
    <mesh_term>Polycystic Ovary Syndrome</mesh_term>
    <mesh_term>Body Weight</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

